Testosterone and type 2 diabetes in men

被引：21
|
作者：
Mazur, Allan [1 ]
Westerman, Ronny [2 ]
Werdecker, Andrea [2 ]
Mueller, Ulrich [2 ]
机构：
[1] Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA
[2] Univ Marburg, Inst Med Sociol, Marburg, Germany
来源：
AGING MALE | 2014年 / 17卷 / 01期
关键词：
Aging; fasting glucose; obesity; testosterone; Type; 2; diabetes; HORMONE-BINDING GLOBULIN; METABOLIC SYNDROME; INCREASED RISK; HEALTH; DEFICIENCY; MORTALITY;
D O I：
10.3109/13685538.2013.879113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: To assess from observational data if low testosterone in men is an independent risk factor for high fasting glucose (FG) and for a diagnosis of type 2 diabetes (T2D). Methods: Multivariate analysis of data from 991 male US Air Force veterans who completed six medical examinations over 20 years. Results: Low testosterone was moderately related to high FG, independent of age and obesity. Low testosterone is a very weak predictor of a diagnosis of T2D. Conclusions: In men, low testosterone is an independent risk factor for high FG, comparable to aging and obesity. Low testosterone is a weak predictor of a diagnosis of T2D.
引用
收藏
页码：18 / 24
页数：7
相关论文
共 50 条
  • [41] MORE THAN 8 YEARS OF EXPERIENCE IN TREATING MEN WITH TYPE 2 DIABETES WITH TESTOSTERONE
    Jones, T. H.
    JOURNAL OF MENS HEALTH, 2009, 6 (04) : 398 - 398
  • [42] Effect of Testosterone Therapy on Renal and Endothelial Functions in Men with Type 2 Diabetes Mellitus
    Khripun, Irina A.
    Bova, Elena V.
    Vorobyev, Sergey V.
    DIABETES, 2018, 67
  • [43] Effect of testosterone on lipid metabolism and endothelium in men with type 2 diabetes mellitus and hypogonadism
    Khripun, I
    Vorobyev, S.
    Khripun, A.
    Kogan, M.
    Demidova, A.
    Belousov, I
    EUROPEAN HEART JOURNAL, 2020, 41 : 3827 - 3827
  • [44] Testosterone and NT-proBNP in Type 2 Diabetes mellitus infected men.
    Resl, Michael
    Prager, Rudolf
    Pacher, Richard
    Huelsmann, Martin
    Luger, Anton
    Neuhold, Stephanie
    Elhenicky, Marie
    Kautzky-Willer, Alexandra
    Clodi, Martin
    Abrahamian, Heidemarie
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S23 - S23
  • [45] DEPRESSION SIGNIFICANTLY REDUCES THE RESPONSE TO TESTOSTERONE THERAPY IN MEN WITH TYPE 2 DIABETES AND HYPOGONADISM
    Hackett, G. I.
    Bhartia, M.
    Cole, N.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 240 - 240
  • [46] Glycemic benefits with adherence to testosterone therapy in men with hypogonadism and type 2 diabetes mellitus
    Jenkins, Craig R.
    Rittel, Alex
    Sturdivant, Rodney X.
    Wan, Jen
    Clerc, Philip G.
    Manning, Evan
    Jenkins, Lydia M.
    Wardian, Jana L.
    Graybill, Sky D.
    ANDROLOGY, 2021, 9 (04) : 1076 - 1085
  • [47] Low Serum Testosterone Concentrations in Hospitalized Men with Poorly Controlled Type 2 Diabetes
    Kim, Kyung-Soo
    Kang, San-Ha
    Kim, Moon-Jong
    Kim, Soo-Kyung
    Kim, Yoo-Lee
    Park, Won-Keun
    Park, Seok Won
    Cho, Yong-Wook
    ENDOCRINOLOGY AND METABOLISM, 2014, 29 (04) : 574 - 578
  • [48] Type 2 Diabetes and Testosterone Therapy
    Hackett, Geoffrey
    WORLD JOURNAL OF MENS HEALTH, 2019, 37 (01): : 31 - 44
  • [49] Prevalence and prognosis of a low serum testosterone in men with type 2 diabetes: the Fremantle Diabetes Study Phase II
    Hamilton, Emma J.
    Davis, Wendy A.
    Makepeace, Ashley
    Lim, Ee Mun
    Yeap, Bu B.
    Peters, Kirsten E.
    Davis, Timothy M. E.
    CLINICAL ENDOCRINOLOGY, 2016, 85 (03) : 444 - 452
  • [50] Men with Latent Autoimmune Diabetes and Type 2 Diabetes May Have Different Change Patterns in Free Testosterone
    Ding, Bo
    Li, Feng-fei
    Zhai, Xiao-fang
    Ye, Lei
    Hu, Yun
    Ma, Jian-hua
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
12345